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Abstract 
Background: Adherence to evidence-based guidelines is essential for the treatment outcome 
of psychotic disorders. Previous studies showed that IT-supported pathways are able to 
increase guideline adherence in psychiatric care. This paper describes a pilot study on the 
development of an electronic recall-reminder-system (RRS) for supporting guideline-adherent 
treatment in outpatient care of patients with chronic psychotic disorders and analyses its 
feasibility. 
Methods: Guidelines were integrated in the RRS software M.E.M.O.R.E.S. Software training 
for the staff was provided. We compared the number of conducted vs. guideline-
recommended interventions 6 months before and after implementation. Subsequently both the 
caregivers’ and the patients’ satisfaction with the RRS was evaluated. 
Results: Guideline adherence in general was low and the RRS was barely used. After its 
implementation a significant increase was observed in chemogram-check-ups and diagnostics 
regarding cardiovascular risks (esp. ECG). Both patients and professionals described 
problems with integrating the RRS in their daily routine and questioned the usefulness of the 
guidelines for chronically ill, although they basically approved its importance and usefulness. 
Conclusions: Participants appreciated the idea of supporting guideline adherence with an IT-
system, but there seemed to be major obstacles to implementation: caregivers appear to be 
concerned of being exposed or questioned, technical difficulties might lead to avoidance, and 
there seems to be a lack of knowledge and awareness about the health risks for individuals 
with psychotic disorders. Possibly guidelines adapted for the chronically ill would find more 
acceptance. Technical simplifications and better information should be considered prior to 
further attempts to implement IT-supported guidelines in order to increase acceptance. 
 
Keywords: clinical guidelines, guideline adherence, psychotic disorders, treatment, IT-
pathway-systems, acceptance 
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Zusammenfassung 
Hintergrund: Die Einhaltung evidenzbasierter Behandlungsleitlinien ist wesentlich für das 
Behandlungsergebnis bei psychotischen Erkrankungen. Studien haben gezeigt, dass IT-
unterstützte Behandlungspfade die Leitlinienadhärenz in der psychiatrischen Versorgung 
erhöhen können. Diese Arbeit beschreibt eine Pilotstudie über die Entwicklung eines 
elektronischen Erinnerungssystems (recall-reminder-system, RRS) zur Unterstützung 
leitlinienbasierter Therapie in der ambulanten Behandlung von psychotischen Erkrankungen 
und untersucht die Machbarkeit. 
Methoden: Die Behandlungsleitlinien wurden in die RRS-Software M.E.M.O.R.E.S 
integriert. Die Fachpersonen erhielten Schulungen für den Gebrauch der Software. Es wurde 
die Zahl der durchgeführten Interventionen 6 Monate vor und nach der Implementierung des 
RRS verglichen. In der Folge wurde ausserdem die Zufriedenheit von Patienten und 
Fachpersonen mit dem System evaluiert. 
Ergebnisse: Die Leitlinienadhärenz war allgemein niedrig und das RRS wurde kaum 
verwendet. Nach der Implementierung war ein signifikanter Anstieg bei der Durchführung 
von Blutuntersuchungen und der Kontrolle kardiovaskulärer Risiken (insbesondere EKG-
Untersuchungen) zu verzeichnen. Sowohl Patienten wie auch Fachpersonen beschrieben 
Schwierigkeiten, das RRS in die tägliche Routine zu integrieren, obwohl sie der Wichtigkeit 
und Nützlichkeit des Systems grundsätzlich zugestimmt haben. 
Fazit: Die Unterstützung leitlinienorientierter Behandlung mit einem IT-System wurde von 
den Teilnehmenden positiv bewertet, es schienen allerdings grosse Hürden bei der praktischen 
Umsetzung zu bestehen: Fachpersonen befürchten möglicherweise, hinterfragt oder 
blossgestellt zu werden, technische Schwierigkeiten reduzieren die Akzeptanz für die 
Anwendung des Systems und es scheinen Informationsdefizite und fehlende Achtsamkeit 
bezüglich der Gesundheitsrisiken von Personen mit psychotischen Erkrankungen zu bestehen. 
Technische Vereinfachungen und bessere Wissensvermittlung vor dem Einsatz 
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leitlinienbasierter Behandlungsprogramme sollten in Erwägung gezogen werden, um die 
Akzeptanz zu erhöhen. 
 
Keywords: Behandlungsleitlinien, Leitlinieneinhaltung, psychotische Erkrankungen, 
Behandlung, IT-Behandlungspfad, Akzeptanz 
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Background 
Several national expert panels have published evidence-based guidelines for the treatment of 
mental disorders including schizophrenia [1-3]. Guideline-concordant treatment leads to a 
better outcome for schizophrenic patients regarding psychopathology, hospitalization rates 
and mortality [4-6]. Recent data from the RAISE study also showed that comprehensive 
treatment for first episode psychosis can be implemented and improves functional and clinical 
outcomes [7]. Individuals with severe mental illness, including schizophrenia, have a 
mortality risk 1.5–2.5 times higher than the general population [8-10]. As antipsychotic 
medication seems to contribute to this risk [11-15], important aspects of treatment quality in 
schizophrenia include diagnostic procedures (e.g. MRI, EEG) and regular controls of 
medication side effects to lessen the risk for somatic comorbidities. Patients suffering from 
schizophrenic disorders exhibit an increased mortality rate due to cardiovascular conditions 
and are often incapable of dealing with the risk factors appropriately [16, 17]. Various studies 
claim that the management of cardiovascular risks in patients with severe mental illness needs 
to be improved [18-22]. 
Factors contributing to a generally low guideline adherence in medical care are: technical 
factors (e.g. hardware, software, usability, integration and interface), organisation-related 
factors (e.g. finances, management, training, feedback), logistic factors (e.g. system design, 
work flow, compatibility), behavioural factors (user satisfaction, settings, expectations and 
interdisciplinary collaboration) and professional/informational factors (e.g. clinical 
experience, clinical relevance of the topic, communication processes), and also different 
patient-related obstacles (e.g. opposing cultures, educational, cognitive and attitude 
differences, no adherence to recommendations) [23, 24]. 
IT-supported systems can improve guideline-concordant treatment. The popularity of such 
applications is increasing [25, 26]. Using guideline-based electronic treatment algorithms 
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leads to increased guideline adherence, resulting in a rise of conducted laboratory 
examinations and drug screenings. Furthermore, more adequate doses of neuroleptics were 
prescribed and a reduction in the length of inpatient stay was found [5, 27, 28]. Nevertheless, 
other recommended interventions such as psychoeducation programmes, cognitive trainings, 
assessment of global level of functioning or of positive and negative symptoms had been 
conducted only moderately, if not poorly [27, 29]. 
This paper presents the results of a pilot prospective intervention study investigating whether 
guideline adherence in outpatient treatment of schizophrenia could be increased by 
implementing an electronic recall reminder system (RRS) that informs mental health 
professionals about upcoming guideline-recommended interventions and patients about 
upcoming appointments. Furthermore, we analysed the acceptance of the system. 
Methods 
Development of the RRS 
The most widely used and accepted guidelines for psychotic disorders in the German speaking 
countries were screened. Then the S3-practice guidelines by the German association of 
psychiatry, psychotherapy and neurology (DGPPN) [1] were combined with current 
pharmacological treatment guidelines [30], as the DGPPN guideline did not give exact 
recommendations regarding monitoring of medication. Further interventions included 
psychosocial interventions (e.g. psychoeducation) and structured clinical assessments 
(psychopathology, side effects). Altogether there were 48 guidelines. Most of them were 
medication guidelines and referred to monitoring side effects such as weight gain, glucose 
levels or dyslipidemia. The physical examinations included blood tests and diagnostic 
procedures (ECG, EEG, weight, waist size). Furthermore, the guidelines included specific 
therapeutic interventions, such as psychoeducation, assessment of medication adherence 
(therapeutic drug monitoring) or information about side effects and contraception. This 
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information was supplied to the electronic RRS software “M.E.M.O.R.E.S” (Medical 
Monitoring and Recalling System) [31]. It was implemented at the workplace of each 
professional. All users received special training, and a written user guide was deposited at 
each study site.  
Diagnoses were confirmed according to DSM-IV and the Basel Screening Instrument for 
Psychosis [32]. The appointment adherence was assessed by the German translation of the 
Service Engagement Scale (SES) [33]. It was completed by the caregivers at the time of the 
RRS-implementation (ti) and at the end of the study (te). The medication adherence was 
assessed by the Medication Adherence Rating Scale (MARS) [34].  
Implementation of the Study 
Between November 2011 and May 2012 patients were recruited at 3 psychiatric outpatient 
departments of the University of Basel Psychiatric Clinics (UPK) and at 3 private psychiatric 
practices (former patients of the mentioned outpatient departments). As resident psychiatrists 
did not conduct all physical examinations themselves, 4 general practitioners took part as 
well. Mental health care professionals included psychiatrists and psychiatric nurses. The 
compliance with appointments was the primary outcome measure of the study. Guideline 
adherence and user satisfaction were the secondary outcome parameters. Patients received 
CHF 10 (≈ 11 $) for participation. 
After having registered the patient in the RRS, the professional had to choose the way of 
communication (text message, e-mail, or letter) and the applicable guidelines. The program 
then displayed the date and content of recommended interventions. According to this, the 
patient automatically received a message and was asked to arrange an appointment. The 
therapist had the option to consult the RRS about the recommendation, but was obliged to 
decide individually which interventions were realized. Afterwards the therapist confirmed the 
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examination as completed or noted why it was not done. Any unconfirmed intervention was 
displayed as missed. 
After recruitment of patients the performed interventions were measured for 6 months without 
applying the reminder function of the RRS (“pre-phase”) by evaluating the electronic records. 
In the subsequent 6 months the procedure was repeated with the active RRS (“post-phase”). 
Changes in guideline adherence were measured by comparing the number of interventions 
during pre- and post-phase. 
The satisfaction with the RRS was assessed with semi-structured questionnaires. Professionals 
were asked for satisfaction with software, customer support by the provider and with the study 
itself. Patients were asked for their satisfaction with the messages and the study, and whether 
it led to an increased frequency of examinations or higher treatment costs. 
Data were assessed using the Statistical Package for the Social Sciences (SPSS) 20. To 
analyse the differences between pre- and post-phase, the Wilcoxon test was used for non-
parametric and the T-test for parametric variables (level of significance p=0.05). 
The study was approved by the local Ethical Committee. 
Inclusion/exclusion criteria 
Patients had to be between 14 and 65 years of age and diagnosed with schizophrenia. 
Exclusion criteria were harmful substance use or addiction (excluding cannabis), organic 
brain syndromes, insufficient language skills, severe negative symptoms and acute psychotic 
episodes. 
Statistical Analysis 
A power calculation estimated a required sample size of 43 patients to reach a power of 90% 
(α=0.05). We assumed a drop-out rate of 20%. Therefore, 54 patients would have had to be 
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recruited, in order to show an improvement in appointment adherence by 10% due to the 
application of the RRS. 
The statistical analysis was done with the Statistical Package of the Social Sciences 20 (SPPS 
20). Besides the descriptive analyses of sociodemographic and clinical data, we analyzed 
differences in the means of the frequencies of diagnostic and therapeutic interventions in pre- 
and post-phase. The differences of the means were assessed by using parametric or non-
parametric tests depending on the distribution of the data, to find out whether there were 
differences in pre- and post-phases regarding the number and duration of hospitalizations, 
guideline adherence and kept appointments. 
Additionally, to determine whether the included, excluded and refusing patients differed with 
respect to age and gender, the ANOVA-test for interval-scaled data (age) and the χ2-test for 
nominal-scaled data were performed. 
Results 
Participants 
After having identified 200 patients, a majority of them had to be excluded or refused 
participation. Finally only 20 patients could be included. The main reason for exclusion was 
poor language skills (29,4%), the main reasons for refusing participation were perceived 
additional strain due to study participation (16.4%), refusal of using electronic devices 
(11.9%), satisfaction with actual treatment (11.9%) and unwillingness to take part in studies 
in general (9.7%) or because of previous study participation (6.7%). Included, excluded and 
refusing individuals did not differ regarding age and gender. The participating 13 health care 
professionals comprised 6 psychiatric nurses, 3 specialists of psychotherapy and psychiatry 
and 4 general practitioners. 
Electronic reminder system for guideline-adherent treatment of psychoses I. Franke et al. 
10 
Dropout rate 
At the end of the post-phase complete data of only 18 patients were available for further 
analyses: one included patient did not have an appointment arranged during the whole study 
period, the other patient’s practitioner fell sick. For evaluating patients’ satisfaction with text 
messages data of 17 participants were available as 3 patients did not receive text messages 
(only the professional did). For further analyses of user satisfaction, data of all 20 participants 
were available. 
Guideline adherence 
Laboratory and other diagnostic measures 
Table 1 shows the proportion of performed vs. recommended examinations. 
Insert Table 1 about here 
The results show that guideline concordant monitoring of drug therapy is done in less than 
50% of the cases in the pre-phase and increases to over 90% in the post-phase. During the 
post-phase, a significant increase could be observed regarding chemogram-analyses and a 
tendency to more haematogram-analyses. Also the controls of blood pressure and ECG 
increased significantly. 
Clinical assessment and psychosocial interventions 
Recommendations included assessment of side effects, changes of psychopathology and 
psychoeducation. We found that side effects, compliance and use of illegal substances were 
assessed quite regularly. Psychoeducation was performed either irregular or not at all. A 
written treatment plan was not available. We found no significant differences between pre- 
and post-phases (see Table 2). 
Insert Table 2 about here 
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Reasons for not complying with guidelines 
Health care professionals: 
• Professional competence: 
Appointments were often held by psychiatric nurses who thought that assessing the 
patient’s physical state and psychopathology is a task obliged to the physician. 
Psychiatrists did not see the patients at each consultation. They assessed 
psychopathology and physical state only when major changes were observed. 
• Physical focus: 
Current treatment focussed on the patients’ mental stability and enabling them to 
manage daily routine; aspects of physical health were not considered to be part of the 
treatment. Psychiatrists in private practice generally did not perform physical 
examinations and delegated this to general practitioners. 
• Long-term treatment:  
Some of the recommendations were considered as unimportant for long-term patients; 
regular assessment of psychopathology was considered as unnecessary when there 
were no obvious changes; psychoeducation was not supposed to be a treatment focus 
for chronically ill people. It was also stated that some examinations had taken place 
before the study period. 
• Organisational obstacles: 
Some of the procedures do require a registration process (ECG). Additionally, not all 
instruments were available at all treatment locations. 
• Irregular application: 
Pulse rate and blood pressure were only measured “when needed”; body weight only if 
there were signs of weight gain. 
• Assumed relevance: 
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Additional measurement of waist size wasn’t done, when weight was controlled. Some 
examinations (ECG, EEG or blood glucose) were considered necessary only in case of 
previously suspicious findings. 
• No written documentation: 
Written treatment plans including regular assessments and check-ups did not exist or 
were not updated regularly. 
RRS user acceptance (professionals) 
The users stated the following reasons for not using the RRS service: 
• Lack of integration of the RRS in hospital and medical software systems. 
• Inflexibility: the system should have been more adaptable to individual treatment 
intervals and demands. 
• Difficulties in handling: confusing and non-intuitive system. 
• Questionable viability of guidelines: the physical focus of the guidelines was 
considered as discouraging; furthermore, own standards of care already existed. 
• Study related obstacles: no detailed information on the scope of the study. 
• Top-down support: no instructions on implementing the system by the direct superior; 
undefined responsibility. 
• Patients “requiring” guideline-concordant treatment could not be reached. 
• Low acceptance by patients: use of mobile phone was refused, the telephone turned 
off, change of phone number or no credit; text messages were considered more 
invasive than e.g. e-mails. 
The following positive aspects of the RRS were mentioned: 
• Appreciation of the basic idea of the system (overview of existing guidelines, 
recommendations). 
• Lower risk of forgetting examinations. 
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• Support in daily work, increased integration of treatment standards in routine care. 
RRS user acceptance (patients) 
The results are displayed in Table 3. The results show that many patients had difficulties in 
understanding the content and purpose of the study. At the end of the study still a majority of 
the patients was convinced they should be reminded on arranged appointments via text 
messages, although they showed up to their appointments regularly anyway. The impression 
of several patients that their treatment did not change during the course of the study or 
through the RRS might indicate that they did not perceive additional strain. Only 10% of the 
participants stated that their treatment costs increased due to study-related examinations. 
Insert Table 3 about here 
Discussion 
We found relatively poor guideline concordance both in the pre-phase as in the post-phase. 
The RRS only led to a moderate increase in laboratory controls (chemogram and 
haematogram analyses) and diagnostic examinations (ECG, EEG, weight, blood pressure). 
This result is supported by other studies [5, 27]. Other interventions like assessment of side 
effects and compliance were performed quite regularly with and without the RRS.  
Therapeutic interventions (e.g. psychoeducation) were not performed more often after the 
implementation of the RRS, which is in accordance to other study results as well [27, 29]. It is 
remarkable that psychoeducation was not considered to be necessary in chronically ill 
individuals. Reasons for that decision were not given. Some recommendations, as for example 
a written documentation of a treatment plan, were not realized at all.  
A further result of our pilot study was that the RRS, designed as a supporting tool for 
clinicians, was only partly applied. The finding that most of the professionals basically 
approved the idea of guideline implementation indicates that there is general awareness for its 
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potential usefulness. On the other hand, there seem to be major opposing factors. The users’ 
statements on their satisfaction with the RRS included aspects which have already been 
described as obstacles for a successful guideline implementation in literature: technical, 
organisational and professional factors [23, 24]. These obstacles might be eliminated by better 
institutional support from top down or by improving technical skills and support. Another 
important reason for the low acceptance was the limited readiness of patients and 
professionals to take part in a study.  
Health care professionals criticized, that some guidelines were not applicable for every stage 
of psychosis and gave that as a reason why they did not follow some recommendations. For 
example the question occurred how often psychoeducational interventions should be 
performed with chronically ill individuals. So some recommendations might need to be 
adapted to increase acceptance. On the other hand controlling cardiovascular risk under 
antipsychotic medication is important for individuals with first episode as well as chronical 
psychoses. Acceptance of comprehensive treatment might increase when guidelines become 
more flexible and more focussed on shared decision making. 
A distinct separation of “physical” and “mental” health care of individuals with severe mental 
illness should be avoided as it can cause under-supply. Therefore it seems necessary to raise 
awareness towards aspects of physical health among professionals involved in the care of 
chronically mentallly ill persons. In our study some patients expressed they had expected an 
improvement of their physical treatment by participating in the study.  
The main limiting factor of this study is its low number of patients included and the diversity 
of included professionals. Furthermore, the selected study sites may have contributed to a 
selection of chronically ill people and therefore the sample is not representative for 
schizophrenia patients. Since the RRS was not applied as supposed, the significant results 
may be explained due to other factors as well. Another limitation might be the short duration 
of the study; probably there would have been a higher acceptance if the users would have had 
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more time to get used to the RRS. All results may also have been influenced by the study 
sample of professionals which included almost 50% psychiatric nurses (the most common 
form of institutionalised outpatient care in Switzerland). 
Despite the evident problems in the present study, the feasibility of IT-supported treatment 
pathways should be further addressed, as they might be able to improve the quality of mental 
health care.  
 
Ethical Standards Statement 
All procedures followed were in accordance with the ethical standards of the local ethics 
committee (EKNZ, formerly EKBB) and with the Helsinki Declaration of 1975, as revised in 
2008. 
Statement of Informed Consent 
Informed consent was obtained from all patients for being included in the study. 
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Tables  
Table 1 Guideline adherence, documented examinations 
 
Intervention 
Pre-phase  
(n=17) 
% (SD) 
Post-phase 
(n=18) 
% (SD) 
P 
Follow-up documentation 
90.64   
(14.18) 
90.11 
(15.78) 
1.0 
Therapeutic drug monitoring 
30.96  
(27.05) 
91.68 
(16.65) 
.122 
Laboratory check-ups (haemogram) 
24.91  
(36.78) 
45.86 
(43.27) 
.067 
Laboratory check-ups (chemogram) 
22.64 
(33.83) 
44.91 
(44.93) 
.050 
Diagnostics (ECG, EEG, blood pressure, weight) 
12.26  
(29.19) 
28.78  
(34.31)  
.011 
SD = Standard Deviation 
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Table 2 Clinical assessments and psychosocial interventions 
 
Intervention 
Number of 
patients 
receiving 
interventions 
Number of 
patients 
where 
interventions 
were 
recommended 
Total number 
of 
interventions 
recommended 
Number of 
patients 
receiving 
interventions 
Number of 
patients 
where 
interventions 
were 
recommended 
Total number 
of 
interventions 
recommended 
 
Pre-phase 
(n=17) 
Pre-Phase Pre-phase Post-phase 
(n=18) 
Post-Phase Post-phase 
Assessment of 
side effects1 
16 17 35 17 18 34 
Assessment of 
compliance1 
12 13 17 14 6 6 
Substance use1 9 16 44 11 18 45 
Pregnancy test (4 
female patients)1 
0 4 8 0 4 7 
Psychoeducation2 individually 3 6 individually 0 0 
Treatment plan3 0 10 10 0 3 3 
1
 Recommended twice in the first month of treatment, then quarterly  
2
 Recommended twice in the first month of treatment, then individually  
3
 Recommended annually 
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Table 3 Patient satisfaction (n=17 for reminders, n=20 for whole course) 
 
Item Yes % (n) 
No 
% (n) 
Don’t 
Know 
% (n) 
Were you informed sufficiently 
about the aims of the reminding 
messages? 
88.2 (15) 11.8 (2)  0 
Were you content with the 
reminders? 94.1 (16) 5.9 (1) 0 
Was the effort caused by the 
reminders bearable? 94.1 (16) 5.9 (1) 0 
Did the reminders cause you to 
show up on treatment 
appointments more regularly? 
11.8 (2) 82.4 (14) 5.8 (1) 
Did the reminders improve 
your treatment quality? 29.4 (5) 
 
70.6 (12) 
 
0 
Would you like to continue the 
reminder function after the 
study is finished? 
47.1 (8) 52.9 (9) 0 
Did you receive more 
examinations during the course 
of the study than before? 
 
If yes, were the additional 
examinations bearable? 
20.0 (4) 
 
 
100 (4) 
80.0 (16) 
 
 
0 
0 
Did your treatment costs 
increase during your 
participation in the study? 
10.0 (2) 90.0 (16) 0 
What did you like about the 
study? 
• The patient is responsible for arranging an appointment or not 
• Appointment reminding function was convenient 
• The study involved little effort 
• The regular treatment was not interrupted 
• Interest in the patient’s perspective 
• Reminders support in terms of structuring the day and one’s 
motivation  
• The study’s duration of one year contributed to the study being 
taken seriously 
• The study supports research and help to other mentally ill 
persons 
 
What did you dislike about the 
study? 
• It was unclear why it was necessary to participate in the study, 
as I showed up to appointments regularly anyway 
• If an appointment had been missed, it was stressful to arrange a 
new one 
• Being asked to arrange an appointment by the reminder was 
tenacious 
• A larger effect concerning physical check-ups (e.g. weight and 
discussing physical changes) was expected 
• There were no prompts sent in advance to arranged 
appointments 
• The long talk at the beginning of the study was stressful 
• The study reminds of the own disorder 
• Text messages were annoying, as appointments had already 
been arranged 
• Text messages were received at inconvenient times 
• If certain examinations would have been performed more often, 
they would have had to be paid by the patients 
• The study caused higher costs 
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